Facebook Twitter

THERATECH REPORTS NET OF $1.4 MILLION FOR QUARTER

SHARE THERATECH REPORTS NET OF $1.4 MILLION FOR QUARTER

TheraTech Inc., 417 Wakara Way, a company manufacturing controlled release drugs, had net income of $1.4 million or seven cents per share in the quarter ending Sept. 30, compared with a net loss of $2.8 million or 14 cents per share in the same quarter a year ago.

Company officials said the company's revenue in the quarter was $8.5 million compared with $3.4 million a year ago.In the first nine months of 1996, TheraTech reported net income of $1.2 million of six cents per share compared with a $7.2 million loss or 37 cents per share in the same quarter of 1995. Revenue in the nine-month period totaled $23.7 million compared with revenue of $12.2 million in the first nine months of 1995.